Biotek-snakken — Oktober 2020
-
Video: Cantargia på Life Scienes konferencen d. 23/9-2020 : https://www.proinvestor.com/boards/87267
-
Så meget er jeg ikke inde i MESO, men jeg ville godt turde satse en gang til. Men hvis de skal gennem nye forsøg kan det jo vare noget tid. Muligt at de kan overbevise FDA om andet og muligt at covid-19 giver pote. Men lidt usikker på den korte bane og jeg binder næppe penge i den nu. Har dog en ordre i 9,5 der dog næppe giver gevinst i dag.
-
CANTARGIA AB: CANTARGIA REPORTS FIRST PATIENT TREATED WITH CAN04 IN A US PHASE I STUDY INVESTIGATING COMBINATION WITH PEMBROLIZUMAB
17:10
Cantargia AB today announced that the first patient has started treatment with the antibody CAN04 and pembrolizumab in a phase I clinical trial in USA. The trial continues according to the clinical protocol and will include up to 18 patients.Cantargia develops antibody-based pharmaceuticals against interleukin-1 receptor accessory protein (IL1RAP). The
-
-
Video: Onkology Venture på Life Scienes konference Sep 2020:
https://www.proinvestor.com/index.php?p=debat_1&postid=87283 -
God morgen.
-
God morgen.
-
-
Bristol-Myers henter Myokardia ind i folden for 13,1 mia. dollar: https://www.proinvestor.com/investornyt/668225/bristol-myers-henter-myokardia-ind-i-folden-for-131-mia-dollar
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind